SIRT1 and neuroblastoma: We utilized iterative medicinal chemistry to identify an analog, DDL-214 (Fig. 1A), of our original SirT1-enhancing hit A0322 that increased SirT1 protein levels in ApoE4-expressing N2a (N2a-E4) murine neuroblastoma cells (Fig. 1B).